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Silica nanoparticles trigger the vascular
endothelial dysfunction and prethrombotic
state via miR-451 directly regulating the
IL6R signaling pathway
Lin Feng1,2, Xiaozhe Yang1,2, Shuang Liang1,2, Qing Xu3, Mark R. Miller4, Junchao Duan1,2* and Zhiwei Sun1,2*
Abstract
Background: Safety evaluation is a prerequisite for nanomaterials in a wide range of fields, including chemical
industries, medicine or food sciences. Previously, we had demonstrated that SiNPs could trigger the thrombotic
effects in vivo, but the underlying mechanisms remain unknown. This study was aimed to explore and verify the
role of miR-451a on SiNPs-induced vascular endothelial dysfunction and pre-thrombotic state.
Results: The color doppler ultrasound results showed that SiNPs had the inhibitory effects on aorta velocity and
cardiac output. The histological and ultrastructural analysis manifested that SiNPs could induce the vascular
endothelial damage. In addition, the expression level of MDA was elevated while the activity of SOD and GSH-Px
were decreased in aortic arch triggered by SiNPs, accompanied with the release of iNOS and decline of eNOS in
blood serum. The immunohistochemistry results showed that the positive staining of TF and PECAM-1 were
elevated in a dose-dependent manner induced by SiNPs. The activation of coagulation function occurred via
shortened TT, PT and APTT while the FIB was elevated markedly induced by SiNPs. Coagulant factors (TF, FXa and
vWF) and PLT numbers were increased whereas the levels of anticoagulant factors (ATIII, TFPI and t-PA) were
decreased. Microarray analysis showed that the down-regulated miR-451a could target the gene expression of IL6R,
which further activated the JAK/STAT signaling pathway triggered by SiNPs. Dual-luciferase reporter gene assay
confirmed the directly target relationship between miR-451a and IL6R. Additionally, the chemical mimics of miR-
451a led to attenuate the expression of IL6R/STAT/TF signaling pathway in vitro and in vivo induced by SiNPs, while
the inhibitor of miR-451a enhanced the activation of IL6R/STAT/TF signaling pathway.
Conclusions: In summary, SiNPs could accelerate the vascular endothelial dysfunction and prethrombotic state via
miR-451a negative regulating the IL6R/STAT/TF signaling pathway.
Keywords: Silica nanoparticles, Vascular endothelial dysfunction, Blood prethrombotic state, miR-451, IL6R signaling
pathway
Background
Silica nanoparticles (SiNPs) were widely used in nano-
medicine fields, including diagnosis, drug delivery sys-
tems, gene therapy vector and bioimaging [1]. According
to the World Health Organization (WHO 2017), SiNPs
are currently ranked as the No.2 largest production of
all manufactured nanomaterials in the global market,
with a volume of nearly 1.5 million tonnes (t) per year
[2]. In addition, SiNPs as food additives have an accept-
able daily intake (ADI) of 1.8 mg/kg [3]. Thus, this
large-scale application has implicated the potential re-
lease of SiNPs into the environmental system. Conse-
quently, SiNPs are also become one of the widely
studied nanoparticles in nanotechnology environmental
health and safety (nanoEHS). With the evidence showed
that intratracheally instillation of SiNPs could cross the
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alveolar-capillary barrier and impair vascular homeosta-
sis, cause the systemic inflammation and toxicological
outcomes [4], there is an urgent required to explore and
address the potential adverse effects of SiNPs on cardio-
vascular system [5].
Thrombosis is a key feature of pathological basis in
the progression of severe cardiovascular diseases which
resulting in myocardial infarction, ischemic stroke, deep
vein thrombosis and pulmonary embolism [6]. The Vir-
chow Theory which is widely acceptable for thrombus
formation emphasizes that the thrombosis is closely as-
sociated with vascular endothelial injury, hemodynamic
change and hypercoagulation [7]. Epidemiologic evi-
dences found that long-term exposure to particulate
matter could impact the coagulation function in the
steelworkers via increasing the expression of endogenous
thrombin and thrombus regulatory proteins [8]. A
10 μg/m3 elevation in particulate matter was associated
with a 70% increase in deep vein thrombosis risk [9].
Since 76% of particulate matter is nanoscale particles
which has the larger surface area for biological reactions,
nanoparticles would be expected to produce more strik-
ingly prethrombotic state in vivo than many microscale
particles [10]. However, currently, few studies have fo-
cused on the relationship between nanoparticles and
thrombus. Some studies showed that SiNPs could cause
the aggregation of blood platelets and reduce the expres-
sion of plasminogen activator inhibitors in mice [4]. Re-
cently, our study found that intravenous microinjection
of SiNPs could lead to a hypercoagulable state in zebra-
fish embryos [11]. However, the underlying molecular
mechanisms of SiNPs on thrombus formation remain
unclear.
MicroRNAs (miRNAs) as composed of 19-25 nt small
non-coding RNAs, are considered to recognize and
combine the 3′-non coding region (3′-UTR) of target
mRNA molecule, and affect the expression of target
genes via degrading the mRNA or inhibiting the transla-
tion of target genes [12]. Recent studies have shown that
miRNAs play important roles in a range of cardiovascu-
lar conditions, including arrhythmia, myocardial hyper-
trophy, hypertension, vascular lesions, atherosclerosis
and thrombosis [13, 14]. It was reported that the endo-
thelial progenitor cell-derived exosomes loaded with
miR-126 could promote the deep vein thrombosis in
mice [15]. MiR-145 facilitates the recanalization of arter-
ial thrombosis via JNK signal pathway in a mouse model
of cerebral infarction [16]. And the up-regulation of
miR-495, miR-26a, miR-223 and miR-483-3p played the
inhibition roles on thrombosis [17–20]. An recent study
revealed that the miR-451 was closely linked with nonal-
coholic fatty liver disease (NAFLD) which resulted in the
increasing risk of cardiovascular diseases, metabolic dis-
eases and type 2 diabetes [21]. Epidemiological studies
had also showed that the expression level of miR-451
was positively correlated with coronary heart disease
(CHD) [22]. Yet, to our best knowledge, there was no re-
port on the relationship between miR-451 and coagula-
tion function triggered by SiNPs.
Here, based on our previous study and high through-
put screening of gene chip results, we explored the
mechanism toxicity on the role of miR-451a in the
process of thrombus formation induced by SiNPs. In
addition, the IL6R/STAT/TF signaling pathways was fur-
ther verified with the loss and gain function of miR-451a
in vivo and in vitro. Our findings will provide new
insight in the role of endothelial dysfunction and pre-
thrombotic state triggered by nanoparticles, and may
also provide critical molecular targets to screen the po-
tential toxicity of nanoparticles.
Methods
Silica nanoparticles preparation and characterization
The Stöber technique was used to synthesize SiNPs,
using 2.5 mL tetraethylorthosilicate (TEOS), 50 mL etha-
nol, 4 mL ammonia, and 2 mL water. The suspension
was stirred at 200 rpm for 12 h at 40 °C, centrifuged at
12,000 rpm for 15 min at 4 °C, then washed three times
with deionized water. SiNPs were dispersed in deionized
water, and the size of 500 particles which selected ran-
domly was measured using transmission electron mi-
croscopy (TEM) and Image J software. The zeta
potential and hydrodynamic size of SiNPs were mea-
sured in distilled water, dulbecco’s modified eagle’s
medium (DMEM), DMEM (with 10% serum) and nor-
mal saline by Zetasizer (Nano ZS90; Malvern, UK).
Animal treatment
Six-week old male Sprague-Dawley (SD) rats were pur-
chased from the Animal Experiments Center of Capital
Medical University (Beijing, China) and maintained in a
specific pathogen-free environment with free access to
food and water, 24 ± 1 °C, 50 ± 5% RH and light/dark
cycle per 12 h. Body weight range was 200 ± 20 g at the
time of experiment. Experimental procedures were ap-
proved by the Animal Care and Use Committee in Cap-
ital Medical University with a permit number,
AEEI-2016-087. Based on our previous study, rats were
divided into four groups randomly: the control group
(normal saline), and three concentrations of SiNPs (1.8
mg/kg·bw, 5.4 mg/kg·bw and 16.2 mg/kg·bw) [23]. Each
group (n = 6) were received intratracheal instillation of
suspension every three days for a 30 day period.
Cells culture
Human umbilical vein endothelial cells (HUVECs) were
cultured in Dulbecco’s modified eagle medium (DMEM)
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(Gibco, USA) with 10% fetal bovine serum (Gibco, USA)
in 5% CO2 at 37 °C.
Color Doppler ultrasonography
Doppler ultrasound using Vevo 2100 Imaging System
(FUJIFILM VisualSonics Inc., USA) placed on the skin
with sterile water-soluble gel at 45° inclination against
its flow, and was used to measure descending aorta vel-
ocity and cardiac output (CO) at the 30th day. Flow vel-
ocity and electrocardiogram were recorded for a period
of 60 s quiet free-breathing.
Histopathological and ultrastructure examination
Aorta segments were isolated for pathological assesss-
ment and fixed in 10% formalin solution for 48 h. The
tissues were fixed into the 4% paraformaldehyde, embed-
ded in paraffin, sectioned every 5 μm and stained with
hematoxylin and eosin (H&E), orcein, and periodic acid
Schiff (PAS) methods. Glutaraldehyde-fixed aortic slices
were observed by a transmission electron microscope
(TEM) (JEOL JEM2100, Tokyo, Japan) for assessment of
tissue ultrastructure.
Oxidative damage assessment
Peroxidation- and antioxidant-related indicators, such as
malondialdehyde (MDA), superoxide dismutase (SOD)
and glutathione peroxidase (GSH-Px), were measured in
the rat aortic arch following the manufacturer’s proto-
cols (Nanjing Jiancheng, China).
NO/NOS system detection
Serum nitric oxide (NO) level was quantified by nitrate
reduction according to the protocol from Beyotime In-
stitute of Biotechnology in Shanghai, China. Blood was
drawn from aortaventralis, then clotted for 2 h at room
temperature and centrifuged at 2000 rpm at 4 °C for 20
min. The activation of endothelial nitric oxide synthase
(eNOS) and inducible nitric oxide synthase (iNOS) in
serum were detected by enzyme-linked immune sorbent
assay (ELISA) kit according to the protocols (Cloud--
Clone Corp. China). The absorbance was recorded by a
microplate reader (Themo Multiscan MK3, USA) for
NO at 540 nm and for eNOS and iNOS at 450 nm.
Immunohistochemistry
4 μm-thick TMA slides were deparaffinized with antigen
retrieval in 1 mM EDTA, pH 9.0 for 15 min. Tissue fac-
tor (TF) (Abcam, UK) and platelet endothelial cell adhe-
sion molecule 1 (PECAM-1) (Abcam, UK) were applied
at 1:100 in Sigel Stain antibody diluent (Cell Signaling
Technology, MA, USA) for 1 h. Universal secondary
antibody was applied for 15 min.
Measurement of coagulation and fibrinolytic factors
Coagulation and fibrinolytic factors were evaluated in
blood serum. Four indices of coagulation, including pro-
thrombin time (PT), activated partial thromboplastin
time (APTT), thrombin time (TT) and human fibrino-
gen (FIB), were to ascertain the endogenous/exogenous
coagulation and plasmin function. All biochemical pa-
rameters were determined using commercial kits (Nan-
jing Jiancheng Bioeng Inst., China) according to the
manufacturers’ instructions. Additionally, the serum
levels of TF, coagulation factor X (FXa), vonwillebrand
factor (vWF), antithrombin III (AT III), tissue factor
pathway inhibitor (TFPI), tissue plasminogen activator
(t-PA) and D-dimer (D2D) were determined using
ELISA kits (Cloud-Clone Corp, Wuhan, China) under
the absorbance of 450 nm.
MiR-451a/IL6R detected by dual-luciferase reporter
system
The 3′-UTR of corresponding gene containing
miR-451a binding sites were amplified using overlap
polymerase chain reaction (PCR) with prime sequence
and cloned downstream of the dual-luciferase reporter
gene assay in the pmirGLO vector (Promega, USA).
2.0 × 104 HUVECs in 100 μL growth medium were
maintained in 96-well plates, then were transfected with
100 ng reporter plasmids and 100 nmol/L miRNA
mimics using Lipofectamine 3000 (Invitrogen, Carlsbad,
CA, USA). The cells were harvested 48 h after transfec-
tion and were assayed using the dual-luciferase reporter
gene assay kit (Promega, Madison, WI, USA) according
to the manufacturer’s instructions. Dual-luciferase activ-
ities were normalized to firefly luciferase activities.
Transfection was repeated in triplicate.
Quantitative qRT-PCR assay
Bio-Rad software (CFX96™ optics module) was used to
design optimal primer pairs for qRT-PCR. Total RNA
was extracted from vessel issues using SV Total RNA
Isolation System reagent (Promega, USA). The expres-
sion of miR-451a and the genes expression of Jak1,
Stat3, Tf, Il6r, Fib and Vwf were performed by qRT-PCR
kit (Takara, Japan) according to the manufacturer’s pro-
tocols. Raw data were normalized to the GAPDH values
for each group, and the fold changes were shown as
mean ± S.D. of six independent experiments. Primer
used for qPCR were shown in Additional file 1: Table S1.
Western blot assay
BCA protein kit (Pierce, USA) was used to extract the
total cellular protein. Proteins were transferred to polyvi-
nylidene fluoride membranes (Millipore, USA) by elec-
trophoresis. The proteins of JAK1 (Abcam, UK), STAT3
(Abcam, UK), TF (Abcam, UK), IL6R (CST, USA), FIB
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(Abcam, UK) and vWF (Abcam, UK) were diluted 1000
times with TBS before use. Glyceraldehydes 3-phosphate
dehydrogenase (GAPDH) was regarded as control. The cel-
lulose membrane was blocked in Tris-buffered saline (with
5% non-fat milk powder) for 1 h at 25 °C, then incubated in
the detected proteins overnight. After washed with 0.05%
Tween-20 (TBST) three times, the cellulose membrane was
incubated in horseradish peroxidase-conjugated anti-
mouse/rabbit IgG secondary antibody (CST, USA) for 1 h
at 25 °C, and washed with TBST three times. The relative
densitometric analysis of antibody-bound proteins were cal-
culated by Image J software.
Loss and gain function of miR-451a measurement in vitro
and in vivo
In vitro
MiR-451a mimics or inhibitors synthesized by Oligobio
(Beijing, China) were used to upregulate or downregu-
late the expression level of miR-451a in HUVECs cells.
Cells were seeded in six-well plates and were cultured to
a density of 60%. Based on our previous results, 50 μg/
mL concentration of SiNPs was significantly in cell tox-
icity via increasing concentration exposure in HUVECs
cells [24]. The groups were as follow: control, mimics
NC, inhibitor NC, SiNPs, miR-451a mimics + control,
miR-451a mimics + SiNPs, miR-451a inhibitor + control
and miR-451a inhibitor + SiNPs. Treatments were added
into the plates with Lipofectamine 3000 (Invitrogen,
Thermo Fisher, USA). After 24 h incubation, the trans-
fection efficiency of miR-451a expression was confirmed
using qPCR. After over- or low-expression cells of
miR-451a were cultured in six-well plates for 24 h, then
incubated with pmirGLO vector (Oligobio, Beijing,
China) using Lipofectamine 3000. After incubation in
normal culture atmosphere for 48 h, the expression
levels of miR-451a and the genes expression of IL6R,
JAK1, STAT3, TF, FGA, FGB and FGG were measured by
qPCR assessment. The proteins of JAK1, STAT3, TF,
IL6R and FIB were detected by western blot assay.
In vivo
MiR-451a mimics synthesized by Oligobio (Beijing,
China) were used to upregulate miR-451a levels in male
SD rats. The groups were as follow: negative control
(NC), miR-451a mimics, SiNPs (16.2 mg/kg·bw),
miR-451a mimics + SiNPs (16.2 mg/kg·bw). After given
SiNPs through tracheal instillation for 5 times in SD
rats, the expression levels of miR-451a and the genes ex-
pression of Il6r, Jak1, Stat3, Tf and Vwf were detected
both in the blood serum and aortic arch. The protein
levels of IL6R, JAK1, STAT3, TF and vWF were detected
by western blot assay.
Statistical analysis
One-way analysis of variance (ANOVA) and least signifi-
cant difference (LSD) were used to determine the vari-
ance and compared different treatment groups by SPSS
23.0. *p < 0.05 was accepted as statistical significance.
Results
Characterization of SiNPs
SiNPs were near-spherical (Fig. 1a) with the average
diameter of 58.11 ± 7.30 nm and a normal size
Fig. 1 Characterization of SiNPs. (a) TEM images showed the spherical and well-dispersed particles. (b) Normal distribution diagram with a mean
diameter of 58.11 ± 7.30 nm. (c) Size distribution by intensity. (d) Zeta potential distribution
Feng et al. Particle and Fibre Toxicology           (2019) 16:16 Page 4 of 13
distribution (Fig. 1b). Hydrodynamic size and zeta po-
tential of SiNPs in different mediums are shown in Fig.
1c-d and Additional file 1: Table S2. Zeta potential was
− 32.7 ± 1.7 mV in distilled water and − 30.8 ± 1.2 mV in
normal saline. Our data demonstrated that SiNPs have
good dispersibility in testing medium.
Hemodynamic changes induced by SiNPs
The blood flow velocity and blood flow volume were de-
tected by Doppler ultrasound after exposure to SiNPs
for 30 days (Fig. 2). Compared with control group, the
descending aorta velocity was decreased from 1278
mm/s in control to 894 mm/s in SiNPs-treated group
(16.2 mg/kg). In addition, the cardiac output was de-
creasing significantly from 108 mL/min to 83 mL/min
in SiNPs-treated group compared with control. Our
data from Doppler ultrasound indicated that SiNPs
could decrease the blood flow velocity and change the
hemodynamics.
Histopathological and ultrastructural changes of vascular
endothelium exposed to SiNPs
Results from the ultrastructure analysis showed that the
normal structure of vascular endothelium were observed
in the aortic arch of the control group (Fig. 3a) and the
low dose of SiNPs-treated group (Fig. 3b). While the
vacuolation of endothelial cells and the dissolution of
nucleus were observed in medium dose group (Fig. 3c).
And in the high dose of SiNPs-treated group, the swol-
len mitochondria and exfoliative endothelial cells were
occured (Fig. 3d). The histopathological assessment
showed that although the morphology of aortic arch was
normal in both control group (Fig. 3e) and low dose
group (Fig. 3f ), there was a number of inflammatory
cells, aortic wall and tunica media thickness were oc-
curred in the higher dose of SiNPs-treated groups (Fig.
3g and h). Taken togerther, the results illustrated that
SiNPs could cause vascular endothelial injury in vivo.
Effects of SiNPs on vascular oxidative damage, NO/NO
system and vascular function
The oxidative damage, NO/NOS system and tissue fac-
tor (TF) expression were measured in the aortic arch in-
duced by SiNPs (Fig. 4). The lipid peroxidation levels of
MDA were increased significantly compared with con-
trol group; whereas the antioxidant activities of SOD
and GSH-Px were decreased markedly in a
dose-dependent manner (Fig. 4a, b and c). In addition,
the serum levels of NO and eNOS were decreased sig-
nificantly, while the activity of iNOS was increased in a
Fig. 2 Hemodynamic changes induced by SiNPs. (a) Control (b) 16.2 mg/kg·bw (c) Descending aorta velocity. (d) Cardiac output. The descending
aorta velocity and cardiac output were decreased from 1278 mm/s to 894mm/s and from 108 mL/min to 83 mL/min compared with the control
in 16 mg/kg·bw group induced by SiNPs. Data were expressed as means ± S.D. from six independent experiments. *p < 0.05 compared with
control without SiNPs and any mimics/inhibitor
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dose dependent manner after exposed to SiNPs(Fig. 4d,
e and f). What’s more, the immunohistochemistry re-
sults showed that the positive cell staining of TF was
mainly located in the vascular endothelium (Fig. 4g).
Notably, as shown in Fig. 4h, the protein level of TF in
high dose of SiNPs-treated group was significantly ele-
vated (14.5-fold higher than that in control). And the
number of PECAM-1 positive cells were also increased
in vascular endothelium (Additional file 1: Figure S1).
Taken together, our data demonstrated that SiNPs
caused the vascular oxidative damage, disturbed the
NO/NOS system and impaired the endothelial function.
Effects of SiNPs on coagulation function
Coagulant factors (TF, FXa, D2D and vWF) and anti-
coagulant factors (ATIII, TFPI and t-PA) were measured
in serum after SD rats exposed to SiNPs for 30 days
(Fig. 5). Decreased TT and APTT were evidented in
some concentrations of SiNPs. Decreased PT and ele-
vated FIB were also observed after treatment with SiNPs.
The expression of TF, FXa, vWF and D2D elevated,
while the expression of AT III, TFPI and t-PA decreased
in dose-dependent of SiNPs. Our results indicated that
SiNPs could impact the coagulation function via activat-
ing the endogenous/exogenous coagulation system and
fibrinolytic system.
Verification of miR-451a/IL6R target regulatory
relationship
As shown in Fig. 6a and Additional file 1: Table S3,
microarray and bioinformatics analysis revealed that
miR-451a has the possible target regulatory relationships
with several genes, such as il6r, stat3, acsl4l, fos, txndc5,
and so on. miR-451 was associated with JAK-STAT sig-
naling pathway, Adipocytokine signaling pathway, and
Toll-like receptor signaling pathway (Fig. 6b and
Fig. 3 Histopathological and ultrastructural changes of vascular endothelium exposed to SiNPs. Results from the ultrastructure analysis showed
that the ultrastructure of endothelial cells and basal membrane were integrated in control group (a) and 1.8 mg/kg·bw group (b). Local
vacuolation of endothelial cells and the dissolution of nuclei were observed in 5.4 mg/kg·bw group (c). Swollen of mitochondria and the
exfoliative endothelial cells were observed in 16.2 mg/kg·bw group (d). Morphology of aortic arch was normal in both control group (e) and 1.8
mg/kg·bw group (f), whereas inflammatory cells and edema appeared in 5.4 mg/kg·bw group (g) and 16.2 mg/kg·bw group (h)
Feng et al. Particle and Fibre Toxicology           (2019) 16:16 Page 6 of 13
Fig. 5 Effects of SiNPs on coagulation function. Decreased TT (a) and APTT (b) demonstrating a trend towards increased blood coagulation in
response to high concentration of SiNPs. Increased FIB (c) and shortened PT (d) are associated with increased blood viscosity and
hypercoagulation. Increased TF (e) and FXa (f) demonstrated the activation of exogenous and endogenous coagulation systems. Increased vWF
(g), PLT (h) and D2D (l) were detected. The anti-coagulative and fibrinolytic system were inhibited by decreasing AT III (i), TFPI (j) and t-PA (k).
Data were expressed as means ± S.D. from six independent experiments. *p < 0.05 and **p < 0.01 compared with control without SiNPs and
any mimics/inhibitor
Fig. 4 Effects of SiNPs on vascular oxidative damage, NO/NO system and vascular function. The level of MDA (a) was increased, while the
activities of SOD (b) and GSH-Px (c) were decreased in a dose dependent manner. The activity of NO (d) and eNOS (f) decreased markedly and
the activity of iNOS (e) increased with increasing SiNPs. Effect of SiNPs on tissue factor (TF) expression in aortic arch sections were detected by
immunohistochemical analysis (g). Expression of TF increased in a dose-dependent manner by SiNPs (h). Data were expressed as means ± S.D.
from six independent experiments. *p < 0.05 and **p < 0.01 compared with control without SiNPs and any mimics/inhibitor
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Additional file 1: Table S4). After transfected with
miR-451a, the significant inhibition occurred in the ex-
pression of luciferase which contains IL6R site 1. On the
contrary, after the mutation of target point, miR-451a
could not inhibit the expression of luciferase, and
miR-451a had no inhibit effects on the expression of lu-
ciferase which contains IL6R site 2 (Fig. 6c).
Dual-luciferase reporter gene assay confirmed the dir-
ectly target regulatory relationship between miR-451a
and IL6R.
The role of SiNPs-triggered miR-451a on IL6R/STAT/TF
signaling pathway in vivo
On the one hand, SiNPs could downregulate the expres-
sion of miR-451a and upregulate the genes expression of
Jak1, Stat3, Tf, Il6r and Fib in SD rats’ aortic arch
(Fig. 7a-f ). Similar trends were observed in the related
protein expression induced by SiNPs (Fig. 7g-h). The
high concentration of SiNPs showed more obvious
changes in these indicators of endothelial injury. On the
other hand, the results of transfection experiment in SD
Fig. 6 Microarray analysis and verification of miR-451a/IL6R induced by SiNPs. (a) MicroRNA-Gene-Network. (b) MicroRNA-Pathway-Network. (c)
Dual-luciferase report gene assay verified the target regulatory relationship between miR-451a and IL6R through pmiR-IL6R-WT1 3′-UTR
binding site
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rats manifested that the increased expression of
miR-451a were significantly in miR-451a mimics + con-
trol group and miR-451a mimics + SiNPs group com-
pared with the control. The expression of gene Il6r
increased in SiNPs groups but decreased in miR-451a
mimics group. The genes expression of Jak1, Stat3, Tf
and Vwf had the similar changes with Il6r which showed
the activation of IL6R/JAK/STAT/TF signaling pathway
(Fig. 8a-f ). The proteins of IL6R, JAK1, STAT3, TF and
vWF were detected which showed the consistent trends
with qPCR analysis (Fig. 8g-h). The results in vivo mani-
fested that SiNPs could decrease miR-451a and activate
the IL6R signaling pathway.
The role of SiNPs-triggered miR-451a on IL6R/STAT/TF
signaling pathway in vitro
As shown in Fig. 9, the expression of mimics/inhibitor
NC were almost the same with the control group with-
out SiNPs. The expression of miR-451a was decreasing
in SiNPs group, miR-451a inhibitor + control group and
miR-451a inhibitor + SiNPs group when compared with
the control. The genes expression of IL6R, JAK1 and TF,
were elevating in SiNPs group, miR-451a inhibitor +
control group and miR-451a inhibitor + SiNPs group
while were decreasing in miR-451a mimics + control
group and miR-451a mimics + SiNPs group significantly
when compared with the control. The genes expression
of STAT3, FGA and FGB were elevating in SiNPs group,
miR-451a inhibitor + control group and miR-451a in-
hibitor + SiNPs group. The gene expression of FGG was
decreasing in SiNPs group, miR-451a mimics + control
group and miR-451a mimics + SiNPs group. The results
in vitro were almost consistant with that in vivo.
Discussion
With an ever-increasing development of nanoparticles,
the potential risks of these materials on human health
and environmental safety is of great concern. As nano-
particles were widely used in nanomedicine, the nano-
particles could enter into target tissues via vascular
endothelium [24]. We previously demonstrated that
SiNPs could induce vascular endothelial damage [25].
However, the molecular mechanisms and subsequent
toxicological outcomes of SiNPs-induced endothelial
damage required further elucidation. In this study, we
demonstrate the relationship between miR-451a and
IL6R/STAT/TF signaling pathway in the process of
SiNPs-induced endothelial dysfunction and pre-throm-
botic state.
Repeated intratracheal instillation of SiNPs over 30
days in rats was accompanied by a reduction tendency
regards to aortic blood flow velocity and cardiac volume
Fig. 7 The role of SiNPs-triggered miR-451a on IL6R/STAT/TF signaling pathway in vivo. Decreased miR-451a and increased genes expression of
Il6r, Jak1, Stat3, Tf and Fib were detected after SiNPs exposure (a-f). Protein levels of JAK1, STAT3, TF, IL6R, FIB and vWF were significantly increased
in a dose-dependent manner induced by SiNPs (g). The protein levels of JAK1, STAT3, TF, IL6R, FIB and vWF were caculated by the relative
densitometric analysis (h). Data are expressed as means ± S.D. from six independent experiments. *p < 0.05 and **p < 0.01 compared with control
without SiNPs and any mimics/inhibitor
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Fig. 9 The role of SiNPs-triggered miR-451a on IL6R/STAT/TF signaling pathway in vitro by miR-451a mimics/inhibitor. The expressions of miR-
451a, IL6R, JAK1, STAT3, TF, FGA, FGB and FGG (a-h) were measured in HUVECs. The results of plasmid transfection with miR-451a mimics/inhibitor
on IL6R/STAT/TF pathway (i). The protein levels of IL6R, JAK1, STAT3, TF and FIB were caculated by the relative densitometric analysis (j). Data are
expressed as means ± S.D. from three independent experiments. *p < 0.05 and **p < 0.01 compared with control without SiNPs and
any mimics/inhibitor
Fig. 8 The effects of plasmid transfection with miR-451a mimics in SD rats exposed to SiNPs. Decreased miR-451a and increased genes
expression of IL6R, JAK1, STAT3, TF and vWF were detected after SiNPs exposure (a-f). Protein levels of IL6R, JAK1, STAT3, TF and vWF were
significantly decreased in miR-451a mimics + SiNPs group (g). The protein levels of IL6R, JAK1, STAT3, TF and vWF were calculated by the relative
densitometric analysis (h). Data are expressed as means ± S.D. from six independent experiments. *p < 0.05 and **p < 0.01 compared with
negative control group
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(Fig. 2). Doppler traces showed the velocities present
and temporal pattern of flow through the cardiac cycle
with peak velocity. Blood flow controls the transport of
zymogens, co-factors, enzymes and inhibitory factors to
regulate coagulation and fibrin formation within a grow-
ing thrombus [26, 27]. In the presence of a growing
thrombosis, the flow velocity is increasing in the narrow
part of the vessel, and the total flow rate decreases be-
cause of the clot resistance. The rate of mass transfer in
coagulation reactions determines the rate of thrombin
generation, fibrin deposition and thrombi growth [28].
The interstitial space between platelets regulates the
transport of coagulation proteins and platelet agonists
into and out of thrombi, ultimately determining its
architecture and arrest [29]. Thus, the hemodynamic
changes induced by SiNPs would be expected to pro-
mote coagulation and reduce fibrinolytic function, ultim-
ately increasing the propensity of the blood towards
hypercoagulation.
Endothelial damage has been an important trigger for
coagulation processes. Vascular endothelial cells showed
severe damage with increasing concentration of SiNPs
(Fig. 3). The oxidative stress and inflammatory response
have been verified as key underlying mechanisms of
nanomaterials toxicity. In this study, the ultrastructural
and histopathological alteration to endothelial layers
were accompanied by both oxidative stress and inflam-
mation of the vessel issues in a dose-dependent manner
(Fig. 4). The surface of SiNPs exhibit unsaturated bonds
and different bonding states of hydroxyl which engen-
ders a high capacity of particles to produce reactive oxy-
gen species (ROS) and cause oxidative damage. ROS can
activate nuclear transcription factors-κB (NF-κB) and
c-Jun N-terminal kinase (JNK) signaling pathway, medi-
ate inflammation, endothelial dysfunction and endothe-
lial damage, contributing to the increased expression of
proinflammatory markers and blood coagulation factors
[30]. Our previous study also found that SiNPs could in-
duce oxidative stress and reduce the activity of antioxidant
enzymes, with increasing expression of interleukin-6
(IL-6) and tumor necrosis factor-α (TNF-α), both in vitro
and in vivo [31]. Endothelial damage was also associated
with imbalances in nitrite levels. Blood nitrite levels have
been shown to inversely correlate with platelet aggrega-
tion, and positively correlate with bleeding time [32]. As
well as deriving from arginine via eNOS, NO can also be
generated by a two-step reduction pathway, in which ni-
trate is converted first into nitrite and then into NO. Thus,
the NO/NOS system might promote the thrombotic path-
ways and blood clotting.
Additionally, the expression of related coagulation fac-
tors PECAM-1 and TF were activated by SiNPs (Fig. 4
and Additional file 1: Figure S1). PECAM-1 is an adhe-
sion molecule which is activated as the result of
inflammation. While TF is activated in response to vas-
cular endothelial injury and/or hypercoagulation. Our
results indicated that SiNPs could impact the coagula-
tion function via activating the endogenous/exogenous
coagulation system and fibrinolytic system (Fig. 5). Our
previous study showed that endothelial cells could ex-
press TF and activate FVII response to vascular endothe-
lial injury, which then combined to the form of
TF-FVIIa complex at the site of endothelial cells [33].
Damaged endothelial cells could also release von willeb-
rand factor (vWF) which promotes the platelet activa-
tion, adhesion and aggregation. SiNPs could also elevate
the expression of fibrinogen and soluble E-selectin in
plasma which indicated the coagulation dysfunction
[34]. Thrombin is a fundamental mediator of coagula-
tion cascade. Only 0.5% of blood coagulation factor
(VII) is activated (FVIIa). This factor could rapidly acti-
vate Factor X (FXa) under the presence of phospholipids
and Ca2+. FXa activates clotting factors to promote the
blood coagulation cascade sequentially [35]. We sug-
gested it is necessary to explore the underlying mechan-
ism of SiNPs on coagulation fuction and thrombus
formation.
The dual-luciferase reporter gene assay and microarray
analysis were further conducted (Fig. 6). While miR-451
has two subunits (miR-451a and miR-451b), according
to our results, only miR-451a had detected the target re-
lationship with gene IL-6R. Thus, we extrapolated that
miR-451a might be the subunit which has the biological
effects. Based on our data, the miR-451a has a target
regulatory relationship with IL6R and has a closely rela-
tionship with JAK/STAT/TF signaling pathway. After
verified the results in vivo and in vitro (Fig. 7-9),
miR-451a was confirmed as a regulator of IL6R in
SiNPs-induced blood hypercoagulation. The expression
of miR-451a in coronary sinus samples from patients
with congestive heart failure were decreased signifi-
cantly [36]. Downregulation of miR-451 promotes
acute proliferation of macrophages and smooth
muscle cells, thereby inducing tissue-engineered vas-
cular graft (TEVG) stenosis and contribute to the de-
velopment of hypertrophic cardiomyopathy (HCM)
[37]. To the contrary, upregulation of endogenous
miR-451 targeting endothelial cells (ECs) is involved
in the modulation of myocardial ischemia-reperfusion
(MI/R) injury [38]. So, the increasing miR-451 might
be a biomarker of prognosis in clinical therapy of
heart failure [39]. IL-6 can phosphorylate JAK and
cause STAT3 up-regulation through glycoprotein 130
(GP130/IL6ST). IL-6 family play important roles in
pathological process of cardiovascular diseases, and
the IL6R-mediated JAK/STAT signaling pathway has
been shown to participate in angiogenesis regulation
and inflammation response [40].
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In our study, miR-451a was detected as a possible key
miRNA in the process of coagulation induced by SiNPs.
Our previous study showed that the IL-6-mediated JAK/
STAT signaling pathway played an important role in
toxic effect of SiNPs-treated in zebrafish [41]. Here, the
mimics/inhibitors of miR-451a transfected into
SiNPs-treated endothelial cells was performed. The IL6R
expression was reduced markedly by mimics of
miR-451a, whereas miR-451a inhibitors obviously ele-
vated the level of IL6R. Therefore, we could infer that
miR-451a may interfere with the IL6R-STAT3 pathway
to regulate the endothelial dysfunction and prethrombo-
tic state induced by SiNPs. However, the protein
corona-mediated alteration by biosurface interaction of
SiNPs may suppress acute toxicity [42]. A cryopellet
containing silica can activate intrinsic blood coagulation
in rotational thromboelastometry [43]. When nanocar-
rier materials enter the body, it will contact with the
blood inevitably and have various reactions with blood
cells and proteins in blood system. It can be recognized
by body immune system to generate complex immune
responses. Also, high surface charge and low density of
nanoparticles can induce platelet aggregation and activa-
tion, and result in thrombosis by activating endogenous
coagulation pathway [44]. Therefore, our study privided
one of molecular mechanism of hypercoagulation in-
duced by nanoparticles which could offer a new thought
to solve the blood toxicity of nanoparticles. The further
research on the biosurface between nanoparticles and
blood components is also required.
Conclusions
For the first time, this study demonstrated that SiNPs
could trigger the vascular endothelial dysfunction and a
prethrombotic state via miR-451a negative regulating the
IL6R/STAT/TF signaling pathway. Our data suggested
that miR-451a could be a useful molecular target for
countering the potential side-effects of promising
nanoparticle-based biomedical applications.
Additional file
Additional file 1: Figure S1. Effects of SiNPs on cellular adhesion
molecule expression in SD rats’aortic arch sections were detected by
immunohistochemical analysis. The expression of PECAM-1was increasing
in a dose-dependent manner compared to the control group. (A) Control
(B) 1.8 mg/kg·bw (C) 5.4 mg/kg·bw (D) 16.2 mg/kg·bw. Table S1. Primers
used for qRT-PCR. Table S2. Hydrodynamic size and zeta potential of
SiNPs in distilled water, DMEM, DMEM (10% serum) and normal saline as
dispersion medium at different time points.Table S3. The top microRNA-
gene ranked by degree over 5 in Signal-Net analysis. Table S4 The
summary of 16 significant pathways involved in 11 microRNA.
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